Published: January 12, 2017

Introduction {#sec1}
============

Totipotency is the capacity to form an entire organism, including embryonic and extraembryonic tissues. In mouse, totipotency lasts from fertilization at embryonic day (E)0 until the morula stage (∼E2.5). Loss of totipotency, early in pre-implantation development, is accompanied by segregation of the first lineage: the outer trophectoderm (TE) that separates from the inner cell mass (ICM). At implantation (∼E4.5), the ICM further generates two distinct layers: the epiblast and the primitive endoderm (PrE, also known as hypoblast) ([@bib2]). At this stage, lineage identities are dictated by the expression of specific transcription factors (TFs). The pluripotent epiblast fate is induced by the expression of *Oct4*, *Nanog*, and *Sox2* ([@bib41], [@bib42]); the segregated PrE layer is positive for *Oct4*, *Gata4*, *Gata6*, *Sox7*, and *Sox17*, whereas the cells of the TE express *Cdx2* ([@bib4], [@bib34]). At earlier stages, these determinants are not specific: in the morula, embryonic and extraembryonic TFs are co-expressed in all blastomeres ([@bib6], [@bib14], [@bib17], [@bib33], [@bib40]).

Proceeding with development, the epiblast forms all embryonic tissues but also the extraembryonic mesoderm of the visceral yolk sac, the chorion, the allantois, and the amnion. The PrE subsequently gives rise to the parietal endoderm (PE) of the transient parietal yolk sac and the visceral endoderm (VE). The VE consists of embryonic and extraembryonic VE. The extraembryonic VE, together with extraembryonic mesoderm, forms the visceral yolk sac, while the embryonic VE is necessary for correct anterior-posterior patterning of the embryo. In addition, recent findings suggest that embryonic VE also contributes to the gut ([@bib23]). The TE forms trophoblast giant cells, the extraembryonic ectoderm and its derivatives, the ectoplacental cone, and the chorionic ectoderm. TE is necessary for implantation of the conceptus and exchange of products between the maternal and fetal circulation.

Mouse embryonic stem cell (ESC) lines are derived from the ICM of developing blastocysts at ∼E3.5 ([@bib15], [@bib29]). ESC lines capture many features of the epiblast and are defined as pluripotent because they can differentiate into the three definitive germ layers of the embryo when injected in recipient blastocysts or aggregated with morulas. In addition, pluripotent ESC lines can also generate trophoblast ([@bib20]) and PrE cell types in vitro (i.e., extraembryonic endodermal cells \[XENs\]) ([@bib22], [@bib32]), aside from cells of the three germ layers of the embryo. There is also evidence that ESCs rarely contribute to extraembryonic lineages in vivo ([@bib5]). Taken together, these data indicate that ESC cultures contain precursors of extraembryonic lineages.

Traditionally, ESCs were derived and cultured in the presence of leukemia inhibitory factor (LIF) and either bone morphogenetic protein 4 (BMP4) or fetal bovine serum (BMP4/L or FBS/L) ([@bib43]). Under such conditions, ESC cultures are heterogeneous and contain metastable and fluctuating subpopulations, resembling later (post-implantation epiblast) or earlier (two-cell stage) developmental stages ([@bib19], [@bib27]). Recently, efficient and clonal derivation from ICM cells ([@bib7]) was reported by using a defined medium containing two inhibitors of MEK and GSK3β kinases together with LIF (2i/L). ESC lines cultured in 2i/L maintain a less heterogeneous "naive" ground state ([@bib28], [@bib45]).

Early in development, PDGFRα has a relatively weak but well visible expression in all blastomeres until it becomes stronger in PrE-committed cells around E3.75 (around 64 cells) ([@bib4], [@bib16], [@bib34]). Here, we demonstrate that PDGFRα^+^ cells can also be identified in undifferentiated ESC cultures. The PDGFRα^+^ subpopulations show a unique PrE-primed molecular and epigenetic signature, which is reflected by functional in vitro and in vivo differences when compared with the epiblast counterpart (PECAM1^+^). Despite these differences, the transcriptome of PDGFRα^+^ cells displays similarities with naive ESCs and with early/mid blastocyst cells. These findings suggest that PDGFRα^+^ cells are the equivalent of the in vivo PrE (hypoblast) precursors present at the pre-implantation stage.

Results {#sec2}
=======

ESC Cultures Contain a PDGFRα^+^ Subpopulation When Cultured without 2i {#sec2.1}
-----------------------------------------------------------------------

Expression of PDGFRα has been reported in differentiating ESCs and in XEN cells, but not in undifferentiated ESC lines. Here, we investigated its expression by using a *Pdgfrα*^*H2B-GFP/+*^ reporter line ([@bib18]) in which the H2B-GFP fusion protein tracks its presence. GFP^+^ cells were detected within colonies of ESC lines, cultured in LIF and knockout serum replacement (KSR/L) ([@bib10]) ([Figure 1](#fig1){ref-type="fig"}A). The comparison between GFP^+^ and negative cells by qRT-PCR, upon separation by fluorescence-activated cell sorting (FACS), showed that *Oct4* transcript levels in PDGFRα^+^ cells were similar to those detected in PDGFRα^−^ cells, while *Nanog* and *Sox2* transcripts were expressed at lower levels ([Figure 1](#fig1){ref-type="fig"}B). Transcript levels of genes associated with early extraembryonic fate (*Gata4*, *Gata6*, *Sox7*, *Sox17*, *Hnf1β*, and *Fgfr2*) were higher in the PDGFRα^+^ fraction ([Figure 1](#fig1){ref-type="fig"}B). Although cells with a PrE profile ([@bib11]) have been described as *Hex*^*+*^, the *Hex* transcript levels were identical in the two fractions ([Figure 1](#fig1){ref-type="fig"}B).

We next stained E14 and R1 ESCs cultured in KSR/L with antibodies against PDGFRα, OCT4, and GATA4. This confirmed the presence of a PrE-primed subpopulation ([Figure 1](#fig1){ref-type="fig"}C, top plot), as ±80% of the PDGFRα^+^ cells co-expressed OCT4 and GATA4 ([Figure 1](#fig1){ref-type="fig"}C, bottom plot and 1D), differently from PDGFRα^−^ cells, which expressed OCT4 only. We also found co-staining for PDGFRα and GATA6 ([Figure 1](#fig1){ref-type="fig"}E), using a *Sox17*^*:GFP/+*^ ESC line between SOX17 and PDGFRα (\>50% of PDGFRα^+^ were GFP^+^, [Figure S1](#mmc1){ref-type="supplementary-material"}A), and between SOX17 and OCT4 ([Figure S1](#mmc1){ref-type="supplementary-material"}B). The molecular identity (OCT4, GATA4, GATA6, and SOX17) of PDGFRα^+^ cells strongly resembles the pre-implantation (∼E3.75) PrE precursor ([@bib4]).

During the transition from morula to early blastocyst stage, cells co-express markers that later become specific for either epiblast or PrE. We tested whether PECAM1, a marker of epiblast in ICM and ESCs, was co-expressed with PDGFRα, to understand if expression of epiblast and PrE surface markers was mutually exclusive in vitro. We identified three different subpopulations: PECAM1^+^/PDGFRα^−^ (epiblast-primed), PECAM1^+^/PDGFRα^+^ (double-positive), and PECAM1^−^/PDGFRα^+^ (PrE-primed) cells ([Figures 1](#fig1){ref-type="fig"}F, 1G, and [S1](#mmc1){ref-type="supplementary-material"}C). Consistently, in the *Sox17*^*:GFP/+*^ ESC line, a subpopulation of PECAM1^+^ cells was also GFP^+^ ([Figures S1](#mmc1){ref-type="supplementary-material"}D and S1E).

Previous reports suggested that culture in 2i/L maintains the expression of early endodermal genes ([@bib11], [@bib28]). To test this, we cultured the *Pdgfrα*^*H2B-GFP/+*^ ESCs for 3 days in 2i/L. As shown in [Figure S2](#mmc1){ref-type="supplementary-material"}A, this resulted in a loss of GFP^+^ cells, a decrease of extraembryonic transcripts (*Gata4, Gata6, Sox7, Sox17, FoxA2*, and *Hnf1β*), and an increase of *Nanog* ([Figure S2](#mmc1){ref-type="supplementary-material"}B); whereas an increase of extraembryonic transcripts levels was seen upon 2i withdrawal ([Figure S2](#mmc1){ref-type="supplementary-material"}C). To confirm the effect of naive culture conditions, we adapted the R1 ESC line to 2i/L for 3 weeks ([Figure 1](#fig1){ref-type="fig"}H). In 2i/L, the PDGFRα^+^ subpopulations were strongly reduced. Subsequent withdrawal of 2i leads to the appearance of the double-positive subpopulation in 2 days and of the PrE-primed subpopulation in 4 days ([Figure 1](#fig1){ref-type="fig"}H, left plots). When culture conditions were again switched to 2i/L, the PDGFRα^+^ subpopulations almost completely disappeared in 6 days ([Figure 1](#fig1){ref-type="fig"}H, right plots). To determine whether the loss of PDGFRα^+^ cells was due to decreased proliferation or increased apoptosis of the PDGFRα^+^ cells, we performed triple intracellular staining for PECAM1, PDGFRα, and either KI67 (proliferation marker) or active CASPASE3 (apoptotic marker). This analysis showed that, under 2i/L, the proliferation of PDGFRα^+^ cells decreased ([Figure S2](#mmc1){ref-type="supplementary-material"}D) without a significant increase in cell death ([Figure S2](#mmc1){ref-type="supplementary-material"}E), demonstrating that the faster proliferating epiblast-primed subpopulation became predominant and took over the culture.

Molecular and Functional Differences of the PDGFRα^+^ Subpopulations {#sec2.2}
--------------------------------------------------------------------

As we could co-detect epiblast and PrE surface markers ([Figure 1](#fig1){ref-type="fig"}F), we confirmed the expression of epiblast and PrE TFs at the single-cell level by performing triple intracellular staining for OCT4, GATA4, and NANOG ([Figure 2](#fig2){ref-type="fig"}A). This showed that ∼8% of the cells co-expressing OCT4 and GATA4 (top left plot) also expressed NANOG (top right plot).

While comparing the different subpopulations, we detected in epiblast-primed cells high levels of the pluripotency transcripts (*Oct4*, *Nanog*, *Sox2*, and *Esrrβ*) as well as proteins (OCT4, NANOG, and SOX2), but low/no expression of PrE-related genes ([Figures 2](#fig2){ref-type="fig"}B and 2C). By contrast, in the PrE-primed cells, *Oct4* transcripts and protein could be detected, whereas NANOG and SOX2 could not. Moreover, expression of markers specific for an extraembryonic ([Figure 2](#fig2){ref-type="fig"}B) but not of post-implantation epiblast fate (*Fgf5*, *T*, *Nodal*, *Nr0b1*, and *Otx2*; [Figure S3](#mmc1){ref-type="supplementary-material"}A) ([@bib9]) were significantly higher in the PrE-primed cells than in the other two-cell populations. Double-positive cells had an intermediate phenotype with respect to both single positive subpopulations.

To further characterize the three cell populations, they were isolated by FACS and subjected to in vitro functional tests. First, we cultured them at clonal density in KSR/L medium. In contrast to epiblast-primed and double-positive cells, PrE-primed cells poorly re-adhered to gelatin-coated plastic and rarely formed ESC colonies; they grew as single cells, resembling XEN cells ([@bib22]) and stained positive for alkaline phosphatase ([Figure 2](#fig2){ref-type="fig"}D). Time course FACS analysis showed that epiblast-primed and double-positive cells re-established the initial heterogeneity in a week when cultured in KSR/L, differently from PrE-primed cells, which strongly maintained a bias for the seeded subpopulation ([Figures 2](#fig2){ref-type="fig"}E and [S3](#mmc1){ref-type="supplementary-material"}B), even when replated in 2i medium ([Figure S3](#mmc1){ref-type="supplementary-material"}C).

We also tested whether PrE-primed sorted cells could be propagated in a stable and pure form by culturing them in medium that allows the derivation of OCT4^+^/GATA4^+^ PrE lines from rat blastocysts ([@bib26]). However, prolonged culture (\>3weeks) of PrE-primed sorted cells resulted in a mixture of cells with epiblast and PrE morphology and TFs (data not shown).

Second, we compared their differentiation potential into definitive endodermal by culturing them with Wnt3a and Activin A ([@bib39]). Time course analysis showed that *Goosecoid, Eomes*, and *Mixl1* could be detected in epiblast-primed and double-positive cells, but not in PrE-primed cells, while *T* was upregulated specifically in epiblast-primed progeny ([Figures 3](#fig3){ref-type="fig"}A and 3B). Differently, *Sox17*, *Sox7*, *Foxa2*, and *Cxcr4* (markers for definitive endoderm and for PrE-derivatives) were expressed from the beginning of the differentiation in PrE-primed and double-positive cells but not in epiblast-primed cells, wherein these markers were only upregulated at later stages. We also found that PDGFRα^+^ subpopulations fail to generate mesendoderm, suggesting a preferential differentiation toward PE/VE cell types. Similarly, upon induction of neuroectodermal lineage ([@bib43]), neural precursors were only detected in epiblast-primed progeny (arrows, [Figure S3](#mmc1){ref-type="supplementary-material"}D). Double-positive and PrE-primed subpopulations formed vacuolated structures (empty arrows, [Figure S3](#mmc1){ref-type="supplementary-material"}D), resembling differentiating XEN cells ([@bib22]).

Third, we assessed the capacity of the three cell populations to generate extraembryonic cell types in trophoblast stem cell (TSC) medium, also shown to support the derivation of XEN cells ([@bib32]). PrE-primed cells but not the other two-cell populations formed XEN-like colonies, positive for GATA6 and LAMININ-β2 and expressing PrE transcripts ([Figures 3](#fig3){ref-type="fig"}C and 3E). Although ESCs are not thought to be capable of generating TSCs without genetic manipulation, we evaluated the presence of putative trophoblast cell progeny, i.e., CDX2^+^GATA6^-^ cells ([Figure 3](#fig3){ref-type="fig"}D), as described ([@bib31]). Trophoblast-like progeny was only detected in epiblast-primed and double-positive cells cultures, as confirmed by qRT-PCR for *Cdx2*, *Gata3*, and *Krt7* ([Figure 3](#fig3){ref-type="fig"}E).

Different Epigenetic State of PDGFRα^+^ Subpopulations {#sec2.3}
------------------------------------------------------

DNA methylation is dispensable for the growth of extraembryonic but not of embryonic tissues ([@bib38]); moreover extraembryonic tissues have a lower level of DNA methylation than their embryonic equivalent ([@bib36]). We therefore compared the expression of DNA methylation and hydroxymethylation genes in the three subpopulations. Levels of *Dnmt1*, *Dnmt3l*, and *Tet1* transcripts were significantly lower in PrE-primed cells compared with the other fractions ([Figure 4](#fig4){ref-type="fig"}A), suggesting a lower level of 5-mC and 5-hmC in PDGFRα^+^ cells. In addition, the promoter of intracisternal A-particle (IAP), which has repetitive elements with ±1,000 copies in the *Mus musculus* genome, was significantly less methylated in PDGFRα^+^ cells (±55%) compared with the epiblast-primed cells (±87%, [Figure 4](#fig4){ref-type="fig"}B). Accordingly, the genome-wide levels of 5-mC and 5-hmC in the genomic DNA were lower in PrE-primed cells compared with the other subpopulations ([Figures 4](#fig4){ref-type="fig"}C and 4D).

The in vitro model described here also reflects these crucial differences in methylation between embryonic and extraembryonic tissues. A similar hypomethylated state has been reported for naive ESCs, where 2i reduces DNA methylation by increasing *Prdm14* ([@bib25]). However, *Prmd14* and other genes involved in primordial germ cells specification/imprinting (*Dppa3*, *Dazl*, and *Prdm1*) were lower in PDGFRα^+^ subpopulations ([Figure 4](#fig4){ref-type="fig"}E), suggesting that DNA hypomethylation depends on other mechanisms.

Finally, we compared the transcript levels of genes involved in chromatin regulation. Polycomb repressive complex (PRC)-1 and -2 and their histone modifications are crucial for the dynamic equilibrium and the plasticity of ESCs by acting as transcriptional repressors ([@bib8]). Of note, RNA sequencing (RNA-seq) analysis showed remarkable differences between the three subpopulations for the expression of these epigenetic regulators ([Figure 4](#fig4){ref-type="fig"}E). Compared with the epiblast-primed fraction, the PDGFRα^+^ subpopulations expressed significantly lower levels of *Kdm2b*, *Jarid2* (which respectively recruit PRC1 and PRC2 complex to chromatin) and of *Ezh2*, *Eed*, and *Suz12* (PRC2 components), suggesting a lower level of H3K27 methylation, known to be reduced in extraembryonic cell types ([@bib1], [@bib37]).

The Developmental Potential of PDGFRα^+^ Cells Reflects Their Different Molecular Identity {#sec2.4}
------------------------------------------------------------------------------------------

When ESCs are used to generate chimeras, chimerism is detected in the epiblast lineage that gives rise to all embryonic and to extraembryonic mesodermal tissues. However, ESC progeny has also been described to contribute very sporadically to TE or PrE-derived extraembryonic lineages ([@bib5]). To compare their developmental potential, we injected GFP^+^ ESCs in recipient blastocysts after FACS sorting of the three subpopulations ([Table S1](#mmc2){ref-type="supplementary-material"}). As expected, epiblast-primed cells efficiently colonized epiblast-derived tissues with high degrees of chimerism ([Figure 5](#fig5){ref-type="fig"}A) but not the TE/PrE-derived extraembryonic tissues. Injection of the double-positive subpopulation resulted in chimerism in the embryo proper ([Figure 5](#fig5){ref-type="fig"}B) as well as in the VE ([Figure 5](#fig5){ref-type="fig"}C) and PE ([Figure 5](#fig5){ref-type="fig"}D). PrE-primed cells contributed to both VE ([Figure 5](#fig5){ref-type="fig"}E) and PE ([Figure 5](#fig5){ref-type="fig"}F) but not to epiblast/TE derivatives. The behavior of the PrE-primed subpopulation differs from that of the *Hex*^*+*^ cells ([@bib11]), which showed a low contribution (10%) to PrE-derived tissues while still colonizing the embryo.

PDGFRα^+^ cells have a distinct molecular identity, which is further reflected by different developmental potential in vivo.

PDGFRα^+^ Subpopulations Have a Unique Expression Profile that Resembles Early/Mid Blastocyst Cells {#sec2.5}
---------------------------------------------------------------------------------------------------

To investigate genome-wide differences/similarities between the three subpopulations, we performed RNA-seq. The comparison demonstrated that 292 genes were more than 2-fold differentially expressed in epiblast-primed cells, 41 in double-positive cells, and 2,131 in the PrE-primed subpopulation ([Figure 6](#fig6){ref-type="fig"}A and [Table S2](#mmc3){ref-type="supplementary-material"}). The double-positive cells more closely resemble the PrE-primed state rather than the epiblast-primed state ([Figures 6](#fig6){ref-type="fig"}A and [S4](#mmc1){ref-type="supplementary-material"}B). As PDGFRα^+^ subpopulations appear to have a PrE molecular phenotype, we compared the sorted subpopulations between each other but also with XEN isolated from embryo (eXEN) or converted from ESCs (cXEN), upon Activin A/retinoic acid treatment ([@bib12]). Core and naive pluripotency genes (*Nanog*, *Sox2*, *Esrrb*, *Klf2*, *Tdgf1*, *Gdf3*, *Nr0b1*, and *Fbxo15*) were not expressed or expressed at a lower level in PrE-primed cells and in c/eXEN. Differently, *Utf1, Tbx3*, and *Klf5* were expressed at higher levels in PDGFRα^+^ cells than in epiblast-primed cells ([Figure S4](#mmc1){ref-type="supplementary-material"}A) or e/cXEN (not expressed). By contrast, genes involved in extraembryonic specification were exclusively detected in PDGFRα^+^ cells and e/cXEN. Remarkable differences were seen also for key pathway-associated genes. When compared with other analyzed lines, PDGFRα^+^ cells expressed higher levels of LIF regulators, such as *Lifr* and *Il6st*, and Wnt-associated genes, such as *Lrp5/6* and *Dkk1*. Members of the fibroblast growth factor (FGF) signaling showed also a different pattern: *Fgf4* and *Fgfr1* levels were higher in epiblast-primed cells, while *Fgf3*, *Fgfr2*, and *Fgfr4* were exclusively expressed in PDGFRα^+^ cells ([Figure S4](#mmc1){ref-type="supplementary-material"}A).

Next, we focused on these subpopulations and performed gene set enrichment analysis (GSEA) of the PANTHER (protein analysis through evolutionary relationships) biological process and KEGG (Kyoto encyclopedia of genes and genomes) pathways. Genes upregulated in the PDGFRα^+^ subpopulations were associated with metabolic processes and with lysosome, glutathione metabolism, and glycosphingolipid biosynthesis pathways ([Tables S3](#mmc4){ref-type="supplementary-material"} and [S4](#mmc5){ref-type="supplementary-material"}). Epiblast-primed cells were enriched for terms associated with the cell cycle, focal adhesion, WNT and hedgehog signaling, cancer, developmental processes, and mesoderm/ectoderm development ([Table S5](#mmc6){ref-type="supplementary-material"}). Remarkably, several terms enriched in the PDGFRα^+^ subpopulations (highlighted in yellow in [Tables S3](#mmc4){ref-type="supplementary-material"} and [S4](#mmc5){ref-type="supplementary-material"}) have been reported for 2i/L ESCs, while many terms enriched in the epiblast-primed subpopulation (highlighted in yellow in [Table S5](#mmc6){ref-type="supplementary-material"}) have been reported for FBS/L ESCs when comparing the naive with the primed state of pluripotency ([@bib28]).

We also performed unsupervised hierarchical clustering and principal component analysis (PCA) to visualize the relationship of the three subpopulations with published transcriptomes: two-cell stage ([@bib27]) (2c^+/−^, KSR/L), *Rex1*^*+/−*^ sorted cells, E14 and TNGA ESCs ([@bib28]), and *Hex*^*+/-*^ sorted cells (FBS/L and 2i/L) ([@bib31]). Unexpectedly, as ESCs cultured in 2i/L do not contain the PDGFRα^+^ subpopulations, these analyses showed that the PDGFRα^+^ subpopulations clustered more closely with naive than with other ESC lines ([Figures 6](#fig6){ref-type="fig"}B and 6C). Heatmap comparison of core/naive pluripotency and key pathway-associated genes with previously published transcriptomes ([Figure S5](#mmc1){ref-type="supplementary-material"}) demonstrated that PDGFRα^+^ subpopulations have a unique transcriptome. PDGFRα^+^ cells, differently from the previously described *Hex*^*+*^ cells, have a pronounced PrE-primed signature, while still retaining some pluripotency-related genes (*Oct4*, *Sall4*, *Utf1*, *Tbx3*, *Tfcp2l1*, and *Klf5*). PDGFRα^+^ cells expressed *Dkk1* in an exclusive manner and had higher levels of LIF regulators (*Lifr* and *Il6st*) and FGF signaling members (*Fgf3/10*, *Fgfr2/3/4*).

As major differences could be detected between epiblast- and PrE-primed cells ([Figures 6](#fig6){ref-type="fig"}A and [S4](#mmc1){ref-type="supplementary-material"}B), we assessed their relationship with single cells obtained from 8-cell-stage morula to late blastocyst (LB)-stage embryos ([@bib13]). PCA analysis grouped a subset of early (EB) and mid (MB) blastocyst single cells with PrE-primed and with epiblast-primed cells ([Figures 6](#fig6){ref-type="fig"}D and [S6](#mmc1){ref-type="supplementary-material"}A). GSEA of PrE/epiblast-primed subpopulations with the five most similar in vivo cells revealed upregulation of *Suz12* targets in the PrE cluster ([Figure S6](#mmc1){ref-type="supplementary-material"}B) and DNA binding-related genes in the epiblast cluster ([Figures S6](#mmc1){ref-type="supplementary-material"}C and S6D; [Table S6](#mmc7){ref-type="supplementary-material"}). Thus, PDGFRα^+^ cells have a unique expression profile and surprisingly show similarities with naive ESCs and with EB/MB cells in vivo.

Epigenetic Modifications and Signaling Involved in the Regulation of the PDGFRα^+^ Subpopulations {#sec2.6}
-------------------------------------------------------------------------------------------------

To better understand the mechanisms and signaling governing this heterogeneity, we tested the effect of known epigenetic modifiers and small molecules. Considering the lower level of 5-mC in PrE-primed cells ([Figures 4](#fig4){ref-type="fig"}B and 4C), we added the DNA methylation inhibitor 5-azacytidine (5-AZA) to KSR/L. 5-AZA enhanced the frequency of PDGFRα^+^ cells in a dose-dependent manner ([Figure 7](#fig7){ref-type="fig"}A). Likewise, the addition of dexamethasone, a glucocorticoid hormone involved in DNA demethylation and whose signaling interacts with the JAK/STAT pathway ([@bib35]), increased the PDGFRα^+^ cell frequency ([Figure 7](#fig7){ref-type="fig"}B). The effects of 5-AZA and dexamethasone were combinatorial, resulting in ∼3-fold increase in PDGFRα^+^ cells ([Figures 7](#fig7){ref-type="fig"}B and [S7](#mmc1){ref-type="supplementary-material"}A). Addition of trichostatin A (TSA), a histone deacetylase inhibitor, resulted in a decrease of PDGFRα^+^ cells ([Figure 7](#fig7){ref-type="fig"}B), suggesting that histone acetylation negatively regulates the PrE-primed state.

As PDGFRα was shown to be necessary for eXEN derivation ([@bib3]) and for conversion of ESCs into cXEN ([@bib12]), we compared *Pdgfrα*^*H2B-GFP/+*^ (heterozygous) and *Pdgfrα*^*H2B-GFP/H2B-GFP*^ cells (a null knockin). The absence of the receptor did not alter the percentage of PDGFRα^+^ cells ([Figure 7](#fig7){ref-type="fig"}C) or the transcript levels of pluripotent/extraembryonic genes in the PDGFRα^+^ subpopulations ([Figure S7](#mmc1){ref-type="supplementary-material"}B). Consistently, culture of ESCs with PDGF-AA did not significantly increase the percentage of PDGFRα^+^ cells ([Figure 7](#fig7){ref-type="fig"}D).

As LIF supports the expansion of PrE in pre-implantation development ([@bib30]), we tested if LIF was also necessary for the propagation of PDGFRα^+^ cells. LIF withdrawal combined with the addition of a Janus kinase inhibitor (to block endogenous LIF), inhibited PDGFRα^+^ cell expansion ([Figures 7](#fig7){ref-type="fig"}D and 7E). FGF signaling regulates the segregation of the PrE layer ([@bib42]) by phosphorylation of extracellular-signal-regulated kinase. The simultaneous inhibition of Gsk3β and MEK kinases in 2i/L resulted in the disappearance of PDGFRα^+^ cells ([Figure 7](#fig7){ref-type="fig"}D); this effect was mediated by Mek (PD0325901), and not by the Gsk3β inhibitor, as shown by FACS for PDGFRα and OCT4/GATA4 ([Figures S7](#mmc1){ref-type="supplementary-material"}C and S7D). This confirms the requirement of FGF also for the fluctuation of PDGFRα^+^ cells.

Discussion {#sec3}
==========

During development, PDGFRα has an early, relatively weak but well visible expression from morula stage onward until it becomes stronger in PrE-fated cells at ∼E3.75 (64 cells) ([@bib4], [@bib16], [@bib34]). In this study, we investigated its presence in undifferentiated ESCs, further dissecting their known heterogeneity. By taking advantage of the endogenous expression of PECAM1 and PDGFRα, we defined three different subpopulations that were further characterized ([Figures 1](#fig1){ref-type="fig"} and [2](#fig2){ref-type="fig"}): PECAM1^+^/PDGFRα^−^ (epiblast-primed), PECAM1^+^/PDGFRα^+^ (double-positive) and PECAM1^-^/PDGFRα^+^ (PrE-primed) cells. PrE-primed cells have a distinct molecular identity, as they co-express OCT4, GATA4, GATA6, and SOX17, which differs from epiblast-primed cells, which co-express OCT4, NANOG, and SOX2. Double-positive cells appear to be an intermediate between epiblast- and PrE-primed cells. In line with this, we also identified, at the single-cell level, cells co-expressing OCT4, GATA4, and NANOG. This is reminiscent of the simultaneous expression of epiblast and extraembryonic determinants in early pre-implantation development ([@bib17]).

Although PrE-biased cells have already been described as *Hex*^*+*^ ([@bib11], [@bib31]), PDGFRα^+^ cells have a more pronounced PrE phenotype and a lower expression of epiblast determinants, which are still retained in *Hex*^*+*^ cells ([Figure S5](#mmc1){ref-type="supplementary-material"}). Moreover, our model does not rely on signal amplification and on the use of reporter lines ([@bib11], [@bib31]), allowing the separation of these subpopulations in every ESC line of interest.

In vitro features of the three subpopulations appear to be drastically divergent in terms of self-renewal and differentiation capacity ([Figure 3](#fig3){ref-type="fig"}). Epiblast-primed cells and double-positive cells but not PrE-primed cells could re-establish the initial heterogeneity. When addressing their differentiation potential, PrE-primed cells efficiently generated XEN-like cells but not embryonic or presumptive trophoblast types diversely from epiblast-primed subpopulation.

PDGFRα^+^ cells have a distinct epigenetic state, characterized by a lower level of DNA methylation/hydroxymethylation and by a different pattern of epigenetic regulators ([Figure 4](#fig4){ref-type="fig"}), in line with the notion that extraembryonic tissues ([@bib38]) and their stem cell models ([@bib37]) are hypomethylated.

The distinct epigenetic and molecular profile of PDGFRα^+^ subpopulations was confirmed also by their developmental potential ([Figure 5](#fig5){ref-type="fig"} and [Table S1](#mmc2){ref-type="supplementary-material"}). The double-positive cells could still colonize the epiblast while PrE-primed cells exclusively contributed to PrE derivatives. Again, these in vivo experiments confirmed that PDGFRα^+^ cells closely represent the PrE precursors.

The comparative transcriptome analysis with epiblast-primed cells and with e/cXEN showed that PDGFRα^+^ subpopulations differentially express genes associated with core/naive pluripotency, and with JAK-STAT, WNT, and FGF signaling pathways ([Figure S4](#mmc1){ref-type="supplementary-material"}). Unexpectedly, PCA, hierarchical clustering, and GSEA with previously available datasets, revealed that globally PDGFRα^+^ cells resemble more naive ESCs ([Figures 6](#fig6){ref-type="fig"}B and 6C; [Tables S3](#mmc4){ref-type="supplementary-material"}, [S4](#mmc5){ref-type="supplementary-material"}, and [S5](#mmc6){ref-type="supplementary-material"}). When compared with single cells obtained from early embryos, PrE-primed cells, as their epiblast counterpart, clustered with cells from the EB-MB stage (∼E3.5--E4.0), further demonstrating that PDGFRα^+^ steady states mirror the pre-implantation developmental window ([Figures 6](#fig6){ref-type="fig"}D and [S6](#mmc1){ref-type="supplementary-material"}A).

The mechanisms involved in the regulation of the heterogeneity in vitro ([Figure 7](#fig7){ref-type="fig"}) confirmed previous studies in early development. The percentage of PDGFRα^+^ cells was influenced by: JAK/STAT signaling, shown to support the expansion of PrE in pre-implantation development ([@bib30]); FGF signaling, known to control the segregation of PrE and epiblast in the ICM ([@bib42]) and amount of DNA methylation, is a dispensable mechanism for the growth of extraembryonic lineages ([@bib38]). By contrast, absence of PDGFRα, necessary for the derivation of eXEN ([@bib3]) and cXEN ([@bib12]), did not alter the abundance of PDGFRα^+^ cells in vitro. Together, these results confirm that PDGFRα^+^ cells are the in vitro equivalent of PrE precursors.

This model, which relies on the endogenous heterogeneous expression of PDGFRα, should facilitate and enable studies to gain insights in the factors regulating the early segregation of these different cell types within the ICM and to unravel the mechanisms involved in the different imprinting of embryonic and extraembryonic tissues ([@bib21]). Future studies are needed to determine whether PrE-primed cells recapitulate the imprinting associated with extraembryonic tissues (i.e., paternal imprinting of X chromosome) and whether a similar PrE-primed state is also present in human ESC cultures.

Experimental Procedures {#sec4}
=======================

Cell Culture {#sec4.1}
------------

Undifferentiated ESCs were maintained feeder free on gelatin (EmbryoMax 0.1% gelatin solution, ES-006-B; Millipore)-coated plates, in knockout DMEM (10829-018; Gibco), 20% knockout serum replacement (KSR, 10828-028; Gibco), 2 mM L-glutamine (25030-024; Gibco), 1x minimal essential medium nonessential amino acids (11140-035; Gibco), 1× penicillin-streptomycin (15140-122; Gibco), 100 μM β-mercaptoethanol (31350; Gibco) and 1,000 U/mL recombinant LIF (ESG1107; Chemicon International).

qRT-PCR Analysis {#sec4.2}
----------------

For RNA isolation, the RNeasy Mini-kit/Micro-kit (74104 and 74004; QIAGEN) was used. DNase treatment was achieved using the Turbo DNase kit (1907, Ambion). cDNA synthesis was done with 1 μg of RNA with the Superscript III First-Strand synthesis system (18080-051; Invitrogen). Real-time PCR was analyzed with the SYBR Green Platinum qPCR Supermix-UDG (11733-046; Invitrogen) on a ViiA 7 Real-Time PCR System (Applied Biosystems). Expression was normalized to *β-Actin*. Primer sequences are listed in the [Supplemental Information](#app3){ref-type="sec"}.

Flow Cytometry and Cell Sorting {#sec4.3}
-------------------------------

Single-cell suspensions of ESCs were obtained by dissociating with cell-dissociation buffer (Invitrogen) at 37°C for 20 min. Cells were washed twice with PBS and incubated with conjugated primary antibodies for 30 min on ice in the dark. Cells were washed once with PBS and resuspended for FACS analysis in PBS + 5% FBS. Flow cytometry was performed at the KU Leuven Flow Cytometry Facility using an FACS AriaIII (Becton Dickinson) or an FACS Canto (Becton Dickinson) for analysis. Intracellular staining was performed with the Foxp3/Transcription Factor Staining Buffer Set kit (00-5523-00; Ebioscience), following the manufacturer\'s protocol. Antibodies are listed in the [Supplemental Information](#app3){ref-type="sec"}.

Differentiation Assays {#sec4.4}
----------------------

Upon sorting of the different subpopulations, specific differentiations were performed as described by [@bib39] for mesendodermal differentiation; by [@bib44] for neural differentiation and by [@bib31] for TSC medium.

Culture Test {#sec4.5}
------------

For the experiments described in [Figures 7](#fig7){ref-type="fig"} and [S7](#mmc1){ref-type="supplementary-material"}, 3 × 10^3^ ESCs were sorted and plated in a 6-well plate in ESC medium under the following conditions: (1) no LIF and 1 μM InSolution JAK Inhibitor I (420097; Calbiochem); (2) 2i, 1 μM PD0325901 and 3 μM CHIR99021 (Axon Medchem); (3) 10 ng/mL PDGF-AA (315-18; Peprotech); (4) 20 nM Trichostatin A (TSA; T8552; Sigma); (5) 250 nM dexamethasone (D2915; Sigma); (6) 1 nM to 1 μM 5-AZA (A3656; Sigma); (7) 250 nM dexamethasone (Sigma) and 100 nM 5-AZA.

Immunoblotting {#sec4.6}
--------------

Sorted ESCs were lysed in RIPA buffer (R0278; Sigma) containing complete protease-inhibitor cocktail (04693116001; Roche) for 1 hr at 4°C. Protein concentrations of various samples were quantified using the Pierce BCA protein assay kit (23225; Thermo Scientific) following the manufacturer\'s instructions. To each protein sample, 1 volume of Bio-Rad loading buffer (161-0747, Bio-Rad) and β-mercaptoethanol (at 20:1, Sigma) was added. The samples were heated at 95°C for 10 min, followed by centrifugation at 13,000 × *g* for 10 min. Thirty micrograms of each protein sample was loaded in each lane of a 10% gradient Mini-PROTEAN TGXTM Precast gel (Bio-Rad) and electrophoresed. The resolved proteins were then transferred to Whatman Protan nitrocellulose membrane (Z613630; Sigma). Following blocking with 5% nonfat milk for 1 hr, membranes were incubated at 4°C overnight with primary antibodies. The following day, the membranes were incubated with horseradish peroxidase (HRP)-conjugated secondary antibodies against rat, rabbit, and mouse IgG (Dako). Immunoreactive bands were visualized using Super Signal West Pico chemiluminescent substrate (34087; Thermo Scientific), and signals were detected using a ChemiDoc XRS^+^ System (Bio-Rad). Antibodies are listed in the [Supplemental Information](#app3){ref-type="sec"}.

Bisulfite Sequencing {#sec4.7}
--------------------

Extraction of the genomic DNA isolated from FACS-sorted ESCs was done with the EpiTect Bisulfite kit (59104; QIAGEN). The primer sequences and PCR conditions for amplification of IAP sequences were as described ([@bib24]). The PCR products were cloned using the pGEM-T Easy Vector System I (A1360; Promega). At least 15 colonies for each sample were sequenced and analyzed using Quma software (<http://quma.cdb.riken.jp/>).

5HmC/5mC Dot Blot Assay {#sec4.8}
-----------------------

FACS-sorted ESC subpopulations of genomic DNA was extracted with the PureLink Genomic DNA Mini kit (K182001; Invitrogen). Two-fold serial dilutions were made by mixing DNA and Tris-EDTA in 96-well plates. Twenty microliters of 1 M NaOH/25 mM EDTA was added to each well, the plate sealed, and heated at 95°C for 10 min. Subsequently, plates were cooled on ice and 50 μL of ice-cold 2 M ammonium acetate (pH 7.0) was added to each well, the plates were incubated on ice for 10 min. Subsequently, the denatured DNA was loaded on the nitrocellulose membrane (Bio-Rad), which was washed with 500 μL of 0.4 M NaOH, and rinsed with water. The membrane was air dried for 5--10 min and placed under UV (at 120,000 μJ/cm^2^). The membrane was blocked with 5% nonfat milk in TBST (Tris-buffered saline and Tween 20) for 1 hr, and then incubated with antibodies against 5hmC/5mC O/N at 4°C. The membrane was washed with TBST for 10 min four times, and incubated with HRP-conjugated secondary antibodies (1: 5.000) at room temperature for 1 hr. The membrane was washed with TBST for 10 min four times, incubated with Enhanced ChemiLuminescence (ECL solution, Thermo Scientific) and developed using Chemidoc (Bio-Rad).

Statistical Analysis {#sec4.9}
--------------------

p Values in the qRT-PCR analysis for pairwise differential expression against the epiblast-primed subpopulation were computed using Student\'s two-tailed t test. Experiments including three or more samples/treatment were subjected to one-way ANOVA with subsequent Tukey honest significant difference testing to establish significant changes between any two means.

Blastocyst Injections {#sec4.10}
---------------------

Blastocyst injection studies were approved by the ethical committee for use of animals in research from KU Leuven (Belgium). C57BL/6 mouse ESCs were labeled with eGFP by lentiviral transduction. The eGFP transcription was under the control of elongation factor-1alpha promoter. Following culture in KSR/L, cells were dissociated and different subpopulations were sorted based on PDGFRα and PECAM1 labeling. Sorted cells (6--8 cells) were immediately injected in the blastocoel cavity of CD1 blastocysts. The embryos were transferred the same day to the uterus of pseudopregnant CD1 female mice. Post-implantation embryos were collected at E6.5 from pseudopregnant mice 3.5 days after embryo transfer. Intact post-implantation conceptuses were isolated from decidua, fixed with 4% paraformaldeyde, and immediately imaged using a SteREO Discovery V12 microscope (Zeiss) to determine chimerism.
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![Undifferentiated ESC Cultures Contain PDGFRα-Expressing Cells\
(A) Bright field picture and GFP expression in *Pdgfrα*^*H2B-GFP/+*^ ESC lines. Scale bar, 100 μm.\
(B) qRT-PCR analysis for embryonic and extraembryonic markers in *Pdgfrα*^*H2B-GFP +/−*^ subpopulations. Data are presented as means ± SEM of each transcript from three independent experiments (normalized to *β-Actin*), ^∗^p \< 0.05, t test.\
(C) FACS analysis on E14 ESC lines for the expression of PDGFRα (top plot) and OCT4/GATA4 (bottom plot). The red cloud represents PDGFRα^−^ cells, while the blue cloud represents PDGFRα^+^ cells, n = 3. The gating strategy was based on isotype controls.\
(D) Immunostaining analysis for OCT4 and GATA4 on R1 ESC line. Arrowheads indicate cells co-expressing OCT4 and GATA4. Scale bar, 50 μm, n = 3.\
(E) Immunostaining analysis for GATA6 on *Pdgfrα*^*H2B-GFP/+*^ ESC line. Arrowheads indicate cells co-expressing PDGFRα^H2B−GFP^ and GATA6. Scale bar, 50 μm, n = 3.\
(F) Representative FACS analysis for PDGFRα and PECAM1 on the R1 line, n = 3. For isotype controls, gating strategies, and sorting purities, see [Figure S1](#mmc1){ref-type="supplementary-material"}C.\
(G) Immunostaining for PDGFRα and PECAM1 on the R1 line. Empty arrowheads indicate cells expressing only PDGFRα, full arrowheads indicate cells co-expressing PDGFRα and PECAM1. Scale bar, 50 μm, n = 3.\
(H) Representative time course FACS analysis for PDGFRα and PECAM1 on the R1 line in 2i/L and KSR/L, n = 3. Gating strategy was based on isotype controls.\
See also [Figures S1](#mmc1){ref-type="supplementary-material"} and [S2](#mmc1){ref-type="supplementary-material"}.](gr1){#fig1}

![ESC Cultures Contain Different PDGFRα^+^ Subpopulations\
(A) Representative intracellular FACS analysis for OCT4, GATA4, and NANOG on the R1 line, n = 3. The gating strategy was based on isotype controls.\
(B) qRT-PCR analysis for embryonic and extraembryonic markers in the three subpopulations. Data are presented as means ± SEM of each transcript from three independent experiments (normalized to *β-Actin*), ^∗^p \< 0.05, t test.\
(C) Representative western blot of three independent experiments for OCT4, NANOG, SOX2, GATA4, and GATA6 on sorted cells. B-TUBULIN was used as normalizer.\
(D) Bright field pictures and alkaline phosphatase staining on sorted subpopulations. Scale bar, 100 μm.\
(E) Percentage of each subpopulation 1 week after their respective sorting, calculated from three independent experiments, ^∗^p \< 0.05, t test.\
See also [Figure S3](#mmc1){ref-type="supplementary-material"}.](gr2){#fig2}

![In Vitro Functional Differences of the Three Subpopulations\
(A) qRT-PCR time course analysis for the indicated genes upon Wnt3a/Activin A treatment. Data are represented as means ± SEM of each transcript from three independent experiments (normalized to *β-Actin*).\
(B) Immunostaining analysis for FOXA2 and MIXL1 on sorted subpopulations at day 4. Scale bar, 50 μm, n = 3.\
(C) Immunostaining analysis for LAMININ-β2 and GATA6 on sorted subpopulations after 7 days in TSC medium. Scale bar, 50 μm, n = 3.\
(D) Immunostaining analysis for CDX2 and GATA6 on the different sorted subpopulations after 7 days in TSC medium. Scale bar, 50 μm. n = 3.\
(E) qRT-PCR analysis for XEN and trophoblast-related markers, upon sorting and differentiation. Data are presented as means ± SEM of each transcript from three independent experiments (normalized to *β-Actin*), ^∗^p \< 0.05, t test.\
See also [Figure S3](#mmc1){ref-type="supplementary-material"}.](gr3){#fig3}

![Different Epigenetic State of PDGFRα^+^ Subpopulations\
(A) qRT-PCR analysis for DNA methylation/hydroxymethylation genes upon sorting of the respective subpopulations. Data are presented as means ± SEM of each transcript from three independent experiments (normalized to *β-Actin*), ^∗^p \< 0.05, t test.\
(B) Bisulfite sequencing of IAP sequences. Open circles, unmethylated; closed circles, methylated.\
(C) Representative dot blot for global 5-mC, from three independent experiments. Mouse embryonic fibroblasts (MEF) were used as control as they contain high levels of 5-mC and low levels of 5-hmC.\
(D) Representative dot blot for global 5-hmC from three independent experiments. MEFs were used as control as they contain low levels of 5-hmC.\
(E) Heatmap of epigenetic regulators on sorted subpopulations based on RNA-seq data. Transcript levels are based on FPKM (fragments per kilobase of exon per million fragments mapped). Red and green represent high and low gene expression, respectively.](gr4){#fig4}

![In Vivo Comparison of Developmental Potential\
GFP^+^ ESCs were FACS sorted for PECAM and/or PDGFRα and injected into recipients blastocysts. Scale bar, 100 μm.\
(A) E6.5 chimeric embryo generated from epiblast-primed cells showing the contribution to the embryo proper.\
(B) E6.5 chimeric embryo generated from double-positive cells showing the contribution to the embryo proper.\
(C) E6.5 chimeric embryo generated from double-positive cells showing the contribution to the VE (arrowhead).\
(D) E6.5 chimeric embryo generated from double-positive cells showing the contribution to the PE (arrow).\
(E) E6.5 chimeric embryo generated from PrE-primed cells showing the contribution to the VE (arrowhead).\
(F) E6.5 chimeric embryo generated from PrE-primed cells showing the contribution to the PE (arrow).\
See also [Table S1](#mmc2){ref-type="supplementary-material"}.](gr5){#fig5}

![RNA-Seq Analysis and Comparison with In Vitro ESC Lines and In Vivo Single Cells\
(A) Differentially expressed genes between sorted subpopulations. Adjusted p value \< 0.05 with fold change (log2) \> 1 or \< −1.\
(B) Unsupervised hierarchical clustering with previously published cell lines.\
(C) PCA analysis and explained variance with previously published cell lines. Cell lines with black dots were culture in 2i/L; cell lines with yellow dots were cultured with FBS/L, with the exception of 2C^+/−^, which were cultured in KSR/L.\
(D) PCA analysis and explained variance with in vivo single cells from early embryonic stages.\
See also [Figures S4--S6](#mmc1){ref-type="supplementary-material"}.](gr6){#fig6}

![Epigenetic Modifications and Signaling Involved in the Regulation of PDGFRα^+^ Cells\
(A) Dose response to 5-AZA treatment. Histograms show the percentage of PDGFRα^+^ cells in response to an increasing concentration of 5-AZA, n = 3.\
(B) Fold change in percentage of PDGFRα^+^ cells after 72 hr of treatment under the indicated culture conditions for three independent experiments, ^∗^p \< 0.05 by one-way ANOVA with subsequent Tukey honest significant difference(HSD) test.\
(C) Representative FACS analysis for PDGFRα and PECAM1 in PDGFRα null and heterozygous ESC lines, n = 3. The gating strategy was based on isotype controls.\
(D) Fold change in percentage of PDGFRα^+^ cells after 72 hr of treatment under the indicated culture conditions for three independent experiments, ^∗^p \< 0.01 by one-way ANOVA with subsequent Tukey HSD test.\
(E) Representative FACS analysis for PDGFRα and PECAM1 with LIF (left plot) or without LIF and with Jak Inhibitor (right plot), n = 3. The gating strategy was based on isotype controls.\
See also [Figure S7](#mmc1){ref-type="supplementary-material"}.](gr7){#fig7}
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